Insights from our experts
Subscribe to Our Blog
In this post, we highlight some of the key investments we have made in each of our biorepositories around the world and what that means for our Sponsors.
Read More
With the advancement of precision medicine, molecular and genetic testing is becoming a critical component for patient selection and individual assessment of the risks and benefits of treatment. Known for partnering with sponsors at a very high-level of scientific engagement, the expansion of our molecular suite (1,975 square feet) further enhances our ability to support sponsors with advanced testing to detect pathogenic events at the genome level.
Read More
With significant developments being continually implemented within pharmacovigilance, sponsors and marketing authorisation holders across the globe must ensure they are up-to-date with the frequently changing environment. Our experts explore several instances where CRO support may be required by sponsors.
Read More